GeneDx Holdings (WGS) Cash from Investing Activities Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -8.06% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 84.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.51% |
| Mar 31, 2026 | -83.41% |
| Dec 31, 2025 | -2,033.33% |
| Sep 30, 2025 | 39.56% |
| Jun 30, 2025 | -60.13% |
| Mar 31, 2025 | -1,216.01% |
| Dec 31, 2024 | 89.33% |
| Sep 30, 2024 | 71.41% |
| Jun 30, 2024 | -101.41% |
| Mar 31, 2024 | 282.47% |
| Dec 31, 2023 | -71.39% |
| Sep 30, 2023 | -534.15% |
| Jun 30, 2023 | 91.35% |
| Mar 31, 2023 | 88.19% |
| Dec 31, 2022 | 63.11% |
| Sep 30, 2022 | -18.24% |
| Jun 30, 2022 | -2,807.77% |
| Mar 31, 2022 | 21.65% |
| Dec 31, 2021 | 98.26% |
| Sep 30, 2021 | 99.18% |